Published in
Elsevier, European Journal of Pharmaceutics and Biopharmaceutics, 2(80), p. 410-417
DOI: 10.1016/j.ejpb.2011.11.001
Links
Tools
An alternative single dose parameter to avoid the need for steady-state studies on oral extended-release drug products
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 